Out of work and addicted to the anti-anxiety medication Klonopin, Heather Delaney, a licensed practical nurse from Stratford, checked herself into Bridgeport Hospital in 2011 when she could no longer handle withdrawal without medical help.
Acceptance for medical marijuana is growing among people who swear by marijuana's power to relieve their ills. Older people are choosing marijuana for their aches and pains, parents are moving to states where marijuana is legal for children with seizure disorders, even pet owners are using pot to ease their pup's pain. It's currently legal in 28 states with several more on deck.
A lot more attention has been paid in recent years to addressing the needs of kids with severe developmental delays and diagnoses like autism. But a new study finds that we're not offering the best help to kids who may have more moderate needs.
It’s been declared a national public health emergency. In the United States, the annual number of deaths from opioid overdose has surpassed the number of deaths during the height of the AIDS epidemic in the ‘90s.
But opioid users aren’t the only victims of this crisis.
Dr. Mahendra Patel, a pediatric cancer doctor, has begun giving away medications to some of his young patients, determined not to disrupt their treatments for serious illnesses like leukemia. He's worried Congress will fail to renew funding soon for a health program that pays for the care of millions of children across the country.
The relationship between roughly 3,000 Massachusetts residents and the expanding menu of Bay State gambling options will form a unique data set for researchers around the globe, and a top gaming regulator hopes it will eventually rank among the most historic scientific surveys.
The history of sugar is a complicated one. Once available to only the rich and powerful, sugar now shows up in everything from cereals and soups, to cigarettes and body scrubs. It is known to both have medicinal qualities and to contribute to a variety of health problems.
Pfizer has announced plans to end its research efforts to discover new drugs for Alzheimer's and Parkinson's diseases. The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself "to bring new therapies to patients who need them."